跳至主要内容
临床试验/IRCT20210701051755N1
IRCT20210701051755N1招募中3 期

Evaluation of the effectiveness of herbal mixture based on Boswellia in improving cognitive and behavioral disorders in patients with mild to moderate Alzheimer's disease ,A Randomized Double-Blind Clinical Trial with Placebo-Controlled.

Tehran University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 no limit(—)
性别
All

入选标准

  • people over 50 years old
  • who have been diagnosed with mild to moderate Alzheimer's disease based on a clinical interview with a DSM-V neurologist
  • Minimum primary education

排除标准

  • Major psychiatric disorders such as depression, schizophrenia; psychotic disorders
  • Other causes of dementia include pure vascular dementia, airway dementia, and frontotemporal dementia.
  • Treatable causes of dementia such as metabolic disorders
  • Patients with severe hepatic impairment (Child-Pugh class c), renal (GFR <25 ml / min) and cardiac (EF <15%)
  • Taking the drug memantine
  • Taking any medication or herbal supplement with an effect on cognitive function
  • Reluctance to continue the plan, at any time and for any reason during the study
  • Serious side effects during treatment

研究者

相似试验